Abstract
On the basis of the potent antiviral activity of acyclovir and ganciclovir, selenoacyclovir (2a) and selenoganciclovir (2b) were designed based on bioisoteric rationale and synthesized via the diselenide 7 as the key intermediate. Compound 2a exhibited potent anti-HSV-1 and -2 activities while 2b exerted moderate anti-HCMV activity, indicating that these nucleosides can serve as a novel template for the development of new antiviral agents.
Original language | English |
---|---|
Pages (from-to) | 8734-8738 |
Number of pages | 5 |
Journal | Journal of Medicinal Chemistry |
Volume | 58 |
Issue number | 21 |
DOIs | |
State | Published - 13 Oct 2015 |
Bibliographical note
Publisher Copyright:© 2015 American Chemical Society.